WINGROVE THERESA

PrivateCIK: 1510720
Location

WALTHAM, MA

WINGROVE THERESA (VP of Regulatory Affairs) sold 98.2% of their position (187.67K shares) of IMMUNOGEN, INC. on the open market

Open‑market sale worth $5.56M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderWINGROVE THERESACIK 1510720
IssuerIMMUNOGEN, INC.CIK 855654
Officer· VP of Regulatory Affairs
Since Jan 2019
-187.67K
Net shares
Net seller
$5.56M
Total sold
1
Open market trades
0B · 1S
7
Total transactions
187.67K acquired · 375.33K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+58.90K

Price / share

$4.83

Trade value

$284.49K

% of position

1719.2%
1/16/2024
3.43K62.33K

Common Stock

Direct
M · Option Exercise

Shares

+2.67K

Price / share

$5.75

Trade value

$15.34K

% of position

4.3%
1/16/2024
62.33K64.99K

Common Stock

Direct
M · Option Exercise

Shares

+126.10K

Price / share

$5.25

Trade value

$662.02K

% of position

194.0%
1/16/2024
64.99K191.09K

Common Stock

Direct
S · Sale

Shares

187.67K

Price / share

$29.64

Trade value

$5.56M

% of position

98.2%
1/16/2024
191.09K3.43K
Total

Net shares

+0.00

Net value

-$4.60M

Derivative Transactions3

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

58.90K shares

Shares

58.90K

Strike price

4.83

Held after

0.00

Exercisable

1/16/2024

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

2.67K shares

Shares

2.67K

Strike price

5.75

Held after

1.33K

Exercisable

1/16/2024

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

126.10K shares

Shares

126.10K

Strike price

5.25

Held after

0.00

Exercisable

1/16/2024
WINGROVE THERESA — Insider Transaction (Form 4) Filed Jan 18, 2024 | Finecho